Kerydin, recently approved by the FDA to cure toenail fungus has been touted as the latest and greatest treatment for this stubborn condition. But does it really work? Kerydin and another recently approved medication, Jublia, are topical versions of a new class of antifungals called oxaboroles. They are believed to be better at penetrating the thick nail plate to reach the fungus growing beneath it. Current over-the-counter and prescription antifungals are not effective in penetrating the nail bed. Oral antifungals have been used for years but have potentially dangerous side effects and can interact with other medications.
Although a stronger and more localized treatment sounds promising, both Jublia and Kerydin have mediocre results at best. First of all, these medications need to be applied daily for 48 weeks, and can have potential side effects, such as ingrown toenails, redness, itching, swelling, burning or stinging, blisters and pain. Secondly the cost is prohibitive, a small (4ml) bottle going for $560 dollars – not covered by most insurance. Thirdly, during the entire year of using Kerydin, you are prohibited from getting a pedicure or painting […]